Manulife (Manufacturers Life Insurance)
EIDX

Manulife (Manufacturers Life Insurance)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,136
Closed -$939K – 3203
2020
Q4 		$939K Buy
7,136
+7
+0.1% +$619 ﹤0.01% 1857
2020
Q3 		$360K Hold
7,129
– – ﹤0.01% 2173
2020
Q2 		$320K Sell
7,129
-616
-8% -$28.6K ﹤0.01% 2209
2020
Q1 		$379K Buy
7,745
+436
+6% +$22.2K ﹤0.01% 1963
2019
Q4 		$419K Sell
7,309
-437
-6% -$21.6K ﹤0.01% 2148
2019
Q3 		$284K Buy
7,746
+275
+4% +$10.7K ﹤0.01% 2355
2019
Q2 		$232K Buy
+7,471
New +$203K ﹤0.01% 2540

Manulife (Manufacturers Life Insurance)'s EIDX Position: Q1 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 7,136 shares — an estimated $939K sold.

Manulife (Manufacturers Life Insurance) first reported a position in EIDX in Q2 2019 and held it in 7 quarters. The position peaked at $939K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 7,136 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $939K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Eidos Therapeutics, Inc. Common Stock position peaked at $939K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2021, filed 3 May 2021.